Related Experiment Videos
Measured lung dose correction factors for 50 MV photons
1Radiation Physics Department, Umeå University, Sweden.
Physics in Medicine and Biology
|December 1, 1998
Summary
High-energy therapeutic X-ray beams cause severe dose perturbations in lung tissue, leading to significant underdosage at tumor interfaces. Careful dose calculations are essential for thoracic radiation therapy planning.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiological Physics
Background:
- Thoracic radiation therapy often involves irradiating lung tissue.
- Lung tissue's low density significantly perturbs radiation dose distributions.
- Understanding these perturbations is critical for accurate treatment planning.
Purpose of the Study:
- To quantify dose perturbation effects in lung tissue using a 50 MV therapeutic X-ray beam.
- To investigate the impact of high-energy beams on dose deposition in lung and adjacent tissues.
- To assess the clinical implications of these dose perturbations in thoracic treatments.
Main Methods:
- Measurements were conducted using phantoms simulating lung and soft tissues.
- Cork was used as the lung tissue equivalent, with solid water, PMMA, and polystyrene for soft tissue.
- Radiographic film and a cylindrical ionization chamber were employed for dose measurements.
- A 50 MV therapeutic X-ray beam was utilized, exceeding typical clinical energies for thoracic irradiation.
Main Results:
- Severe degradation of the beam penumbra (up to 2.5 times that in water) was observed in the lung region.
- Lack of electronic equilibrium in low-density lung tissue caused underdosage up to 30% at the lung/tumor interface.
- Build-up depth to 95% of target dose behind the lung extended to 22 mm.
- Dose perturbation effects were found to be highly dependent on patient anatomy and beam size.
Conclusions:
- High-energy X-ray beams (50 MV) induce significant dose perturbations in lung tissue.
- Accurate individual dose calculations are crucial for optimizing photon beam energy selection in thoracic treatments.
- Clinical implementation requires careful consideration of these dose effects to ensure treatment efficacy and patient safety.